Home LiteratureArticle Details
PMID: 6319438 Published · ppublish English Journal Article

Increased contractile strength and tightened adhesions to the substratum result from reverse transformation of CHO cells by dibutyryl cyclic adenosine monophosphate.

Journal of cell science ·Vol. 64 ·1983-11-00 ·Pages 1-11

Leader WM, Stopak D, Harris AK

Abstract

We have examined the changes in cellular contractility and adhesive morphology that accompany the reverse transformation of CHO cells caused by dibutyryl cyclic adenosine monophosphate. The ability of these cells to distort elastic silicone rubber substrata was found to increase markedly over the 5 h period following addition of cyclic AMP and testosterone to the medium, and to relax again following hormone removal. Parallel changes were observed in the interference reflexion image of the adhesion of these cells to glass substrata; broad grey-appearing 'close' contacts characteristic of the transformed state were gradually replaced by numerous small black-appearing 'focal contacts'. These changes in adhesive morphology required considerably longer (20-25 h) to be completed or to revert, however.

MeSH Terms
Animals Bucladesine/pharmacology Cell Adhesion/drug effects Cell Communication Cell Transformation, Neoplastic/pathology Cells, Cultured Cricetinae Female Ovary/pathology Silicone Elastomers Testosterone/pharmacology
Chemicals
Silicone Elastomers Testosterone Bucladesine
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Leader W M
Stopak D
Harris A K
Article Info
Journal
Journal of cell science
Abbr.
J Cell Sci
ISSN
0021-9533
Published
1983-11-00
Pages
1-11
Language
English
Region
England
NLM ID
0052457
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com